KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Other financing activities (2018 - 2019)

Adaptive Biotechnologies (ADPT) has disclosed Other financing activities for 2 consecutive years, with -$5.0 million as the latest value for Q4 2019.

  • Quarterly Other financing activities changed N/A to -$5.0 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was -$6000.0 through Dec 2020, up 50.0% year-over-year, with the annual reading at $321000.0 for FY2020, 2775.0% up from the prior year.
  • Other financing activities hit -$5.0 million in Q4 2019 for Adaptive Biotechnologies, down from $5.0 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $5.0 million in Q3 2019 to a low of -$5.0 million in Q4 2019.